Selective Modulation of TNF-TNFRs Signaling: Insights for Multiple Sclerosis Treatment.

about

Selective Modulation of TNF-TNFRs Signaling: Insights for Multiple Sclerosis Treatment.

Item

http://www.wikidata.org/entity/Q55130300

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Selective Modulation of TNF-TNFRs Signaling: Insights for Multiple Sclerosis Treatment.

@en

Selective Modulation of TNF-TNFRs Signaling: Insights for Multiple Sclerosis Treatment.

@nl

type

Item

label

Selective Modulation of TNF-TNFRs Signaling: Insights for Multiple Sclerosis Treatment.

@en

Selective Modulation of TNF-TNFRs Signaling: Insights for Multiple Sclerosis Treatment.

@nl

prefLabel

Selective Modulation of TNF-TNFRs Signaling: Insights for Multiple Sclerosis Treatment.

@en

Selective Modulation of TNF-TNFRs Signaling: Insights for Multiple Sclerosis Treatment.

@nl

P1476

Selective Modulation of TNF-TNFRs Signaling: Insights for Multiple Sclerosis Treatment.

@en

P2093

Jon D Laman

http://www.w3.org/2001/XMLSchema#string

Ulrich L M Eisel

http://www.w3.org/2001/XMLSchema#string

Valentina Pegoretti

http://www.w3.org/2001/XMLSchema#string

Wia Baron

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes

Disease tolerance as a defense strategy

TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects

Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade

Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pat

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

Resolution of inflammation: the beginning programs the end

Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.

P304

925

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3389/FIMMU.2018.00925

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29760711

http://www.w3.org/2001/XMLSchema#string

P921

peptide

cell surface receptor

membrane proteins

multiple sclerosis

P932

5936749

http://www.w3.org/2001/XMLSchema#string